Jane R. Schwebke

12.9k total citations · 1 hit paper
198 papers, 9.0k citations indexed

About

Jane R. Schwebke is a scholar working on Microbiology, Epidemiology and General Health Professions. According to data from OpenAlex, Jane R. Schwebke has authored 198 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Microbiology, 98 papers in Epidemiology and 67 papers in General Health Professions. Recurrent topics in Jane R. Schwebke's work include Reproductive tract infections research (185 papers), Adolescent Sexual and Reproductive Health (66 papers) and Syphilis Diagnosis and Treatment (60 papers). Jane R. Schwebke is often cited by papers focused on Reproductive tract infections research (185 papers), Adolescent Sexual and Reproductive Health (66 papers) and Syphilis Diagnosis and Treatment (60 papers). Jane R. Schwebke collaborates with scholars based in United States, Kenya and United Kingdom. Jane R. Schwebke's co-authors include Christina A. Muzny, Renée A. Desmond, Tonja R. Nansel, Mark A. Klebanoff, William W. Andrews, Donald E. Burgess, Paul Nyirjesy, Heidi L. Weiss, Rebecca M. Brotman and Edward W. Hook and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Microbiology Reviews.

In The Last Decade

Jane R. Schwebke

196 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sexually transmitted infections: challenges ahead

2017 479 citations Jeanne Marrazzo, Jane R. Schwebke et al. profile →

Peers

Countries citing papers authored by Jane R. Schwebke

Since Specialization

Citations

This map shows the geographic impact of Jane R. Schwebke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane R. Schwebke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane R. Schwebke more than expected).

Fields of papers citing papers by Jane R. Schwebke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane R. Schwebke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane R. Schwebke. The network helps show where Jane R. Schwebke may publish in the future.

Co-authorship network of co-authors of Jane R. Schwebke

This figure shows the co-authorship network connecting the top 25 collaborators of Jane R. Schwebke. A scholar is included among the top collaborators of Jane R. Schwebke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane R. Schwebke. Jane R. Schwebke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis 2021 ·European Journal of Obstetrics & Gynecology and Reproductive Biology X ·Jane R. Schwebke, (unknown), Arthur Waldbaum, Kathy Agnew, Jeremy Ra Paull, Clare F. Price, (unknown), Philip McCloud, G R Kinghorn	20
2	Effect of metronidazole on vaginal microbiota associated with asymptomatic bacterial vaginosis 2021 ·Access Microbiology ·Daniel Ruiz-Perez, Makella Coudray, (unknown), Karl Krupp, Hansi Kumari, Vitalii Stebliankin, Kalai Mathee, Robert L. Cook, Jane R. Schwebke, Giri Narasimhan, Purnima Madhivanan	6
3	A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis 2020 ·PLoS ONE ·Arthur Waldbaum, Jane R. Schwebke, Jeremy Ra Paull, Clare F. Price, Stephanie R. Edmondson, (unknown), Philip McCloud, G R Kinghorn	18
4	Factors Associated With the Recurrence, Persistence, and Clearance of Asymptomatic Bacterial Vaginosis Among Young African American Women: A Repeated-Measures Latent Class Analysis 2020 ·Sexually Transmitted Diseases ·Makella Coudray, Diana M. Sheehan, Li Tan, Robert L. Cook, Jane R. Schwebke, Purnima Madhivanan	4
5	Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study 2019 ·Journal of Clinical Microbiology ·Jane R. Schwebke, Stephanie N. Taylor, Ronald Ackerman, Robert Schlaberg, Neil B. Quigley, Charlotte A. Gaydos, Steven Chavoustie, Paul Nyirjesy, Carmelle V. Remillard, (unknown), (unknown), Damon Getman, Craig B. Clark	38
6	Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance 2019 ·Clinical Infectious Diseases ·(unknown), (unknown), Norine Schmidt, Peter Augostini, W. Evan Secor, Jane R. Schwebke, David H. Martin, Patricia Kissinger, Christina A. Muzny	27
7	An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis 2019 ·The Journal of Infectious Diseases ·Christina A. Muzny, Christopher M. Taylor, W. Edward Swords, Ashutosh Tamhane, Debasish Chattopadhyay, Nuno Cerca, Jane R. Schwebke	182
8	Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis 2019 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·Steven Chavoustie, (unknown), Arthur Waldbaum, Gilbert Donders, (unknown), Jane R. Schwebke, Jeremy Ra Paull, Clare F. Price, (unknown), Philip McCloud, G R Kinghorn	24
9	Delay in Seeking Healthcare Services Following Onset of Urethritis Symptoms in Men 2019 ·PMC ·Kristal J. Aaron, Barbara Van Der Pol, Stephen J. Jordan, Jane R. Schwebke, Edward W. Hook	1
10	Mycoplasma genitalium Infection in Kenyan and US Women 2018 ·Sexually Transmitted Diseases ·Jennifer E. Balkus, Lisa E. Manhart, Jørgen Skov Jensen, Omu Anzala, Joshua Kimani, Jane R. Schwebke, Juma Shafi, Charles Rivers, (unknown), R. Scott McClelland	21
11	Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis 2018 ·Journal of Clinical Microbiology ·Jane R. Schwebke, Charlotte A. Gaydos, Paul Nyirjesy, Sonia Paradis, Salma Kodsi, Charles K. Cooper	74
12	Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women 2017 ·Journal of Clinical Microbiology ·Jane R. Schwebke, Charlotte A. Gaydos, Thomas P. Davis, Jeanne Marrazzo, (unknown), Stephanie N. Taylor, (unknown), Laura H. Bachmann, Ronald Ackerman, (unknown), Daron Ferris, Carey‐Ann D. Burnham, Hilary Reno, (unknown), David L. Eisenberg, Peter R. Kerndt, Susan Philip, Jeanne A. Jordan, Neil B. Quigley	41
13	Secnidazole Treatment of Bacterial Vaginosis 2017 ·Obstetrics and Gynecology ·Sharon L. Hillier, Paul Nyirjesy, Arthur Waldbaum, Jane R. Schwebke, (unknown), (unknown), (unknown)	27
14	Clinical Validation of a Test for the Diagnosis of Vaginitis 2017 ·Obstetrics and Gynecology ·Charlotte A. Gaydos, (unknown), Jane R. Schwebke, (unknown), (unknown), Thomas E. Davis, Kenneth H. Fife, Paul Nyirjesy, (unknown), (unknown), Jenell S. Coleman, Sonia Paradis, Charles K. Cooper	89
15	Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis 2013 ·Microbiome ·Jacques Ravel, Rebecca M. Brotman, Pawel Gajer, Bing Ma, (unknown), Douglas Fadrosh, Joyce M. Sakamoto, Sara S. K. Koenig, Li Fu, Xia Zhou, Roxana Hickey, Jane R. Schwebke, Larry J. Forney	226
16	Development and Validation of a Semiquantitative, Multitarget PCR Assay for Diagnosis of Bacterial Vaginosis 2012 ·Journal of Clinical Microbiology ·Charles P. Cartwright, (unknown), (unknown), Barbara A. Body, Melinda B. Nye, Charles Rivers, Jane R. Schwebke	73
17	HPV Vaccine Implementation in STD Clinics—STD Surveillance Network 2011 ·Sexually Transmitted Diseases ·Elissa Meites, Eloisa Llata, Susan Hariri, Jonathan M. Zenilman, (unknown), Jane R. Schwebke, Irina Tabidze, Christie Mettenbrink, (unknown), Sarah Guerry, Preeti Pathela, Lenore Asbel, (unknown), Kyle T. Bernstein, Roxanne P. Kerani, Eileen F. Dunne, Lauri E. Markowitz	10
18	Use of Vaginal Polymorphonuclear to Epithelial Cell Ratios for the Prediction of Preterm Birth 2005 ·Obstetrics and Gynecology ·Patrick S. Ramsey, (unknown), Alice R. Goepfert, Suzanne Cliver, Jane R. Schwebke, William W. Andrews, Robert L. Goldenberg, John C. Hauth	21
19	Performance of a New, Rapid Assay for Detection of Trichomonas vaginalis 2004 ·Journal of Clinical Microbiology ·Ann Kurth, William L. H. Whittington, Matthew R. Golden, Katherine K. Thomas, King K. Holmes, Jane R. Schwebke	34
20	Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility 2000 ·American Journal of Public Health ·Laura H. Bachmann, (unknown), Rebecca H. Allen, Jane R. Schwebke, Laura C. Leviton, Harvey A. Siegal, Edward W. Hook	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact